Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001638 · ClinicalTrials.gov registry record
Magnetic Resonance Imaging of the Blood Vessels of the Heart
A clinical trial, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 2,916
- Enrollment target
NCT00001638: Completed study, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT00001638 is a clinical trial that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 2,916 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001638 has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 2,916 participants
- Enrollment target
Study Summary
This study is directed at evaluating patients with "myocardial ischemia" or poor blood supply to the heart muscle due to coronary artery disease. The major objective of this study is to determine the level of safety and effectiveness of magnetic resonance imaging at diagnosing coronary artery disease. In addition, this study will allow researchers at the National Institutes of Health to see a broad spectrum of disease, preserve clinical skills, and stimulate future ideas for clinical research....
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,916 participants |
| Start Date | 1997-09-29 |
| Est. Completion | 2009-08-03 |
What the finished NCT00001638 record still lists
NCT00001638 is an observational study that tracks outcomes without assigning an intervention. Its 2,916 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001638 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001638 about?
NCT00001638 is a clinical study titled "Magnetic Resonance Imaging of the Blood Vessels of the Heart". This study is directed at evaluating patients with "myocardial ischemia" or poor blood supply to the heart muscle due to coronary artery disease. The major objective of this study is to determine the level of safety and effectiveness of magnetic resonance imaging at diagnosing coronary artery diseas...
What is the current status of trial NCT00001638?
This trial is currently completed. The enrollment target is 2,916 participants. The study started on 1997-09-29. Estimated completion is 2009-08-03.
Who is sponsoring clinical trial NCT00001638?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05564377 · 2,900 participants · Phase 2
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
- NCT07222995 · 2,900 participants · NA
Hybrid Effectiveness-Implementation Trial to Integrate Precision Skin Cancer Risk Feedback in FQHCs
- NCT06273436 · 2,894 participants · NA
Healing, Equity, Advocacy and Respect for Mamas
- NCT05849961 · 2,946 participants
Exactech Hip Systems Post-Market Clinical Follow-up (PMCF)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI